PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2024 Animal Health Summit on Thursday, February 29, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 11:40 a.m. ET. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations ...

Zoetis, Inc. (ZTS) delivered fourth-quarter 2023 adjusted earnings (excluding one-time items) of $1.24 per share, which missed the Zacks Consensus Estimate of $1.33. In the year-ago quarter, the company delivered earnings of $1.15 per share.Total revenues grew 8% year over year to $2.21 billion, surpassing the Zacks Consensus Estimate of $2.19 billion in the reported quarter. Shares of Zoetis have gained 20.6% in the past year against the industry’s 2.8% decline.Image Source: Zacks Investment ResearchQuarte ...

Zoetis (ZTS) reported $2.21 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 8.5%. EPS of $1.24 for the same period compares to $1.15 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $2.19 billion, representing a surprise of +1.04%. The company delivered an EPS surprise of -6.77%, with the consensus EPS estimate being $1.33.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how th ...

Fourth Quarter and Full Year 2023 Financial Results Forward-looking Non-GAAP Financial Statements Information This presentation contains forward-looking statements, which reflect the current views of We use non-GAAP* financial measures, such as adjusted net income, adjusted diluted Zoetis with respect to: business plans or prospects, future operating or financial earnings per share and operational results (which exclude the impact of foreign exchange), performance, future guidance, future operating models; ...

Zoetis (ZTS) came out with quarterly earnings of $1.24 per share, missing the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $1.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -6.77%. A quarter ago, it was expected that this animal health company would post earnings of $1.35 per share when it actually produced earnings of $1.36, delivering a surprise of 0.74%.Over the last four quarters, the compa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-35797 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 46-0696167 (State or other j ...

In its upcoming report, Zoetis (ZTS) is predicted by Wall Street analysts to post quarterly earnings of $1.33 per share, reflecting an increase of 15.7% compared to the same period last year. Revenues are forecasted to be $2.19 billion, representing a year-over-year increase of 7.4%.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 1.6% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this ...

The market expects Zoetis (ZTS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2023. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on February 13, 2024, might help the stock move higher if these key numbers are b ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Zoetis (ZTS) , which belongs to the Zacks Medical - Drugs industry, could be a great candidate to consider.This animal health company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 3.78%.For the last reported quarter, Zoetis came out with earn ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 13, 2024. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2023 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presenta ...